COMPREHENSIVE HEALTH INSIGHTS
DEAD

Serial Number

85831478

Owner

HUMANA INC.

Attorney

Kenneth Todd Veirs

First Use Date

Feb 28, 2013

Filing Date

Jan 24, 2013

Add to watchlist:

No watchlists yet
View on USPTO

COMPREHENSIVE HEALTH INSIGHTS Trademark

Serial Number: 85831478 • Registration: 4492704

COMPREHENSIVE HEALTH INSIGHTS is a trademark filed by HUMANA INC. on January 24, 2013. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

HUMANA INC. (899 trademarks)

500 WEST MAIN STREET
LOUISVILLE, KY 40202

Entity Type: 03

Trademark Details

Filing Date

January 24, 2013

Registration Date

March 4, 2014

First Use Anywhere

February 28, 2013

First Use in Commerce

April 1, 2013

Cancellation Date

October 9, 2020

Goods & Services

consulting services related to medical cost management; management services of a business nature for clinical trials in the field of investigational drugs; data compilation and analysis in the field of healthcare management, namely, conducting pharmacoeconomics, health economics and statistical research for business purposes; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business consulting services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; supply chain management, namely, tracking and management of clinical trial supplies and research materials used in such; providing statistical information and analysis via computer for use with clinical trial data for business purposes; business consultation services for the healthcare industry; business consulting in the field of clinical and health economic research services for healthcare companies; preparing statistical business reports resulting from clinical trials and laboratory data analysis; consultation in the field of patient recruitment; data preparation for business purposes, namely, preparation of medical and scientific data for use by insurance companies and third party medical reimbursement organizations

consulting services in the field of research and analysis of drug prescription and associated data, namely, regulatory compliance consulting as it applies to prescription drug sampling

consultation in the field of drug use testing services; consultation in the field of healthcare; providing pharmaceutical advice; providing an interactive on-line computer database in the field of medical diagnostics

medical and scientific research, data collection and analysis in the nature of clinical research and conducting clinical trials for others in the fields of healthcare, medical care and pharmaceuticals; scientific research in the field of general health and medical and scientific research, namely, conducting clinical trials by providing clinical indicators calculated using medical claims data that are used to measure quality of medical care; compilation and analysis in the field of scientific and medical research, namely, conducting pharmacoeconomics, health economics, medical laboratory data analysis, and statistical medical research; pharmaceutical development services in the fields of molecular medicine; pharmaceutical development, namely, design, research and development of drugs, pharmaceuticals and medicines for others; clinical development services for others, namely, research and consultation in the fields of pharmaceutical drug development and clinical trial design; medical laboratory data analysis, clinical diagnosis research and diagnostic testing research; preparation of reports and research concerning development of medicines, pharmaceuticals, genetics, biology, biotechnology and pharmaceutical drugs; consulting services in the fields of pharmaceuticals research, and biotechnology fields; management services of a scientific and technical nature for clinical trials in the field of investigational drugs, namely, conducting clinical protocols and trials for others; consulting services regarding scientific aspects of clinical trials of investigational drugs, namely, advising others on conducting clinical protocols and trials; technical writing for others of clinical trial reports; research and consultation in the clinical medical field, namely, research and analysis provided to healthcare providers, suppliers of medical devices and pharmaceutical products, and suppliers of medical software and medical information management services; medical quality evaluation services, namely, providing data collection, analysis, and reporting services for patient data, clinical information, treatment options and treatment success for the medical industry; providing an on-line computer database in the field of health and productivity research and analysis; assessment surveys for health and medical purposes, namely, in research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; quality evaluation services, namely, surveying patients to assess quality of life, burden of disease and overall satisfaction with access to medical care to determine service quality for the medical industry

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 9, 2020 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 4, 2019 REM1
REGISTERED-SUPPLEMENTAL REGISTER
Mar 4, 2014 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 29, 2014 PREV
ASSIGNED TO LIE
Jan 29, 2014 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 7, 2014 CNTA
EXAMINER'S AMENDMENT ENTERED
Jan 7, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 7, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 7, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2014 CNEA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Dec 24, 2013 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2013 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2013 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2013 CNRT
USE AMENDMENT ACCEPTED
Dec 23, 2013 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2013 TROA
AMENDMENT TO USE PROCESSING COMPLETE
Sep 10, 2013 AUPC
USE AMENDMENT FILED
Sep 10, 2013 IUAF
TEAS AMENDMENT OF USE RECEIVED
Sep 9, 2013 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2013 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2013 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2013 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2013 NWOS
NEW APPLICATION ENTERED
Jan 28, 2013 NWAP